A Legacy of Innovation
Merck has a strong history of success in translating cutting-edge research into life-saving medical breakthroughs. Our scientific advances have made a difference in the lives of millions of patients worldwide. From Merck’s development of the first measles and mumps vaccines to treatments for cancer and diabetes, we are an industry leader in bringing forth innovative new medicines. In 2017 Merck had sales of more than $40 billion and we operate in more than 140 countries.
Partnering With Merck
We recognize that building partnerships is one of our most important jobs. In 2017, over 60% of our human health sales were attributable to alliance partnerships and patents. In addition to our headquarters team based in Kenilworth, N.J., we have BD&L professionals in key biomedical innovation epicenters including—Boston, San Francisco, London and Shanghai.
We’re pursuing some of the most innovative areas in biomedical research emerging today without regard to therapeutic area/modality. With 100 business development transactions since 2016, our team has experience working on collaborations from discovery to clinical-stage programs. We believe that by working together we can play a major role in transforming global health care. Together we can invent for life.